{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:00:58Z","timestamp":1785564058476,"version":"3.56.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T00:00:00Z","timestamp":1405555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002999","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T18:47:57Z","timestamp":1405622877000},"page":"e2999","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis"],"prefix":"10.1371","volume":"8","author":[{"given":"Adriano C.","family":"Coelho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana T.","family":"Trinconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H. N.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia R. B.","family":"Uliana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"HW Murray","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis Worldwide and Global Estimates of Its Incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref3","first-page":"159","article-title":"Antigen-specific immunodeficiency and its relation to the spectrum of American cutaneous leishmaniasis","volume":"26","author":"J Convit","year":"1993","journal-title":"Biol Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2133.2007.07872.x","article-title":"Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses","volume":"156","author":"O Zerpa","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"TK Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.trstmh.2006.02.011","article-title":"Oral miltefosine for the treatment of Indian visceral leishmaniasis","volume":"100","author":"S Sundar","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"J Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"<italic>Leishmania donovani<\/italic> Resistance to Miltefosine Involves a Defective Inward Translocation of the Drug","volume":"47","author":"FJ Perez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from <italic>Leishmania<\/italic> involved in drug resistance","volume":"278","author":"FJ Perez-Victoria","year":"2003","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1371\/journal.pntd.0001512","article-title":"Multiple Mutations in Heterogeneous Miltefosine-Resistant <italic>Leishmania major<\/italic> Population as Determined by Whole Genome Sequencing","volume":"6","author":"AC Coelho","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both <italic>L. donovani<\/italic> miltefosine transporter and the new protein LdRos3 in <italic>Leishmania<\/italic> parasites","volume":"281","author":"FJ Perez-Victoria","year":"2006","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e55604","DOI":"10.1371\/journal.pone.0055604","article-title":"Transbilayer dynamics of phospholipids in the plasma membrane of the <italic>Leishmania<\/italic> genus","volume":"8","author":"MG dos Santos","year":"2013","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1590\/S0074-02762011000400015","article-title":"The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant <italic>Leishmania<\/italic> species of Brazil","volume":"106","author":"E Morais-Teixeira","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jac\/dkh380","article-title":"Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against <italic>Leishmania amazonensis<\/italic>","volume":"54","author":"RM Santa-Rita","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0732-8893(03)00093-2","article-title":"PCR diagnosis and characterization of <italic>Leishmania<\/italic> in local and imported clinical samples","volume":"47","author":"G Schonian","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0035-9203(80)90253-9","article-title":"Some methods for the enzymic characterization of Latin-American <italic>Leishmania<\/italic> with particular reference to <italic>Leishmania mexicana amazonensis<\/italic> and subspecies of <italic>Leishmania hertigi<\/italic>","volume":"74","author":"MA Miles","year":"1980","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1101\/gr.122945.111","article-title":"Chromosome and gene copy number variation allow major structural change between species and strains of <italic>Leishmania<\/italic>","volume":"21","author":"MB Rogers","year":"2011","journal-title":"Genome Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","article-title":"Enhancements and modifications of primer design program Primer3","volume":"23","author":"T Koressaar","year":"2007","journal-title":"Bioinformatics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/dnares\/dst031","article-title":"The Genome Sequence of <italic>Leishmania (Leishmania) amazonensis<\/italic>: Functional Annotation and Extended Analysis of Gene Models","volume":"20","author":"F Real","year":"2013","journal-title":"DNA Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e2179","DOI":"10.1371\/journal.pntd.0002179","article-title":"LABCG2, a new ABC transporter implicated in phosphatidylserine exposure, is involved in the infectivity and pathogenicity of <italic>Leishmania<\/italic>","volume":"7","author":"J Campos-Salinas","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1016\/S0021-9258(18)45658-X","article-title":"Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells. Evidence for a protein-mediated and ATP-dependent process(es)","volume":"262","author":"OC Martin","year":"1987","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1242\/jcs.93.2.363","article-title":"Differences in intracellular transport of a fluorescent phosphatidylcholine analog in established cell lines","volume":"93","author":"RG Sleight","year":"1989","journal-title":"J Cell Sci"},{"key":"ref24","first-page":"68","article-title":"<italic>In vitro<\/italic> sensitivity of <italic>Leishmania (Viannia) braziliensis<\/italic> and <italic>Leishmania (Leishmania) amazonensis<\/italic> Brazilian isolates to meglumine antimoniate and amphotericin B","volume":"15","author":"RC Zauli-Nascimento","year":"2010","journal-title":"Trop Med Int Health"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mimet.2013.02.007","article-title":"Parasite burden in <italic>Leishmania (Leishmania) amazonensis<\/italic>-infected mice: validation of luciferase as a quantitative tool","volume":"93","author":"JQ Reimao","year":"2013","journal-title":"J Microbiol Methods"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e1469","DOI":"10.1371\/journal.pntd.0001469","article-title":"Impact of continuous axenic cultivation in <italic>Leishmania infantum<\/italic> virulence","volume":"6","author":"D Moreira","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0169-4758(96)40010-2","article-title":"A simple method for quantifying <italic>Leishmania<\/italic> in tissues of infected animals","volume":"13","author":"HC Lima","year":"1997","journal-title":"Parasitology today (Personal ed)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of <italic>Leishmania<\/italic> species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"P Escobar","year":"2002","journal-title":"Acta Trop"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"<italic>In vitro<\/italic> susceptibility of field isolates of <italic>Leishmania donovani<\/italic> to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity","volume":"53","author":"D Kumar","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exppara.2013.05.015","article-title":"<italic>In vitro<\/italic> drug susceptibility of <italic>Leishmania infantum<\/italic> isolated from humans and dogs","volume":"135","author":"C Maia","year":"2013","journal-title":"Exp Parasitol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of <italic>Leishmania<\/italic> from Peru and Nepal to miltefosine","volume":"73","author":"V Yardley","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"<italic>Leishmania<\/italic> resistance to miltefosine associated with genetic marker","volume":"18","author":"S Cojean","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1107\/S1744309106035779","article-title":"Cloning, purification and preliminary crystallographic analysis of a putative pyridoxal kinase from <italic>Bacillus subtilis<\/italic>","volume":"62","author":"JA Newman","year":"2006","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00436-014-3835-7","article-title":"Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of <italic>Leishmania donovani<\/italic> and <italic>L. infantum<\/italic>","volume":"113","author":"S Hendrickx","year":"2014","journal-title":"Parasitol Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1664","DOI":"10.1371\/journal.pntd.0001664","article-title":"Experimental induction of paromomycin resistance in antimony-resistant strains of <italic>L. donovani<\/italic>: outcome dependent on in vitro selection protocol","volume":"6","author":"S Hendrickx","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijantimicag.2011.11.008","article-title":"Efficacy of miltefosine treatment in <italic>Leishmania amazonensis<\/italic>-infected BALB\/c mice","volume":"39","author":"JL Godinho","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","article-title":"Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of <italic>Leishmania donovani<\/italic> and persists in vivo","volume":"30","author":"K Seifert","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.micinf.2007.01.009","article-title":"Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?","volume":"9","author":"S Rijal","year":"2007","journal-title":"Microbes Infect"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/507710","article-title":"American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?","volume":"194","author":"V Yardley","year":"2006","journal-title":"The Journal of infectious diseases"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T12:21:38Z","timestamp":1649679698000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002999"}},"subtitle":[],"editor":[{"given":"Louis","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,17]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002999","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,17]]}}}